Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Cerebrovasc Dis. 2011;31(6):615-20. doi: 10.1159/000326068. Epub 2011 Apr 13.

    The authors say: 'The data are not so robust because of heterogeneity' - so, how should I deal with this systematic review? Meta-analysis and the clinician.

    Source

    Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, UK. peter.sandercock@ed.ac.uk

    Abstract

    Systematic reviews can, if done well, provide a convenient and unbiased summary of the evidence on a particular topic. The presence of substantial heterogeneity in a meta-analysis is always of interest. On the one hand, it may indicate that there is excessive clinical diversity in the studies included, and that it is inappropriate to derive an estimate of overall effect from that particular set of studies. On the other hand, appropriate exploration of the source of heterogeneity may either identify poor design of the studies included or perhaps not even identify the cause; in either case, investigating the source of the heterogeneity may be identified as a topic for future research.

    Copyright © 2011 S. Karger AG, Basel.

    Comment in

    PMID:
    21494032
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Icon for S. Karger AG, Basel, Switzerland

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk